$SRZN News

We're Not Very Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Rate

Surrozen to Present at Upcoming Healthcare Investor Conference

HC Wainwright & Co. Maintains Buy on Surrozen, Raises Price Target to $44

Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update

Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TD Cowen Initiates Coverage On Surrozen with Buy Rating

HC Wainwright & Co. Reiterates Buy on Surrozen, Raises Price Target to $36

Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Surrozen Files Prospectus To Offer Up To $200M Of Securities

Surrozen Q4 EPS $(20.13) Misses $(1.08) Estimate, Sales $500.000K Inline

Surrozen to Present at Upcoming Healthcare Investor Conference

Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cantor Fitzgerald Initiates Coverage On Surrozen with Overweight Rating, Announces Price Target of $40

Surrozen Conference: CEO Details Wnt-Fzd4 Eye Disease Bet, 2026 IND Plans for SZN-8141

We're Hopeful That Surrozen (NASDAQ:SRZN) Will Use Its Cash Wisely

Surrozen to Present at Upcoming Healthcare Investor Conferences

Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update

Surrozen Appoints Andrew Maleki CFO, Effective Nov. 12, Succeeding Charles Williams

Surrozen Q3 EPS $(8.36) Misses $(1.14) Estimate, Sales $983.000K Down From $10.000M YoY